Positional View
Market Cap - 135+ Crore (Micro Cap)

Bought/Added JOCIL at CMP of 160 - 162, shall add more on dips (if any) till 140 for positional/investment point of view.

View valid as long as 136 is safe on closing basis.

Potential upside:- Upto 169 - 175 - 181 - 188 - 195 - 200 - 210 - 217 - 225 - 232 - 240+

Disclaimer:- I am not SEBI Registered. Please consult your financial advisor and Know Your Company (KYC) before investing. Personally invested/Skin in the game based on my own technical and fundamental skills. View is shared for Educational Purpose only.

JOCIL - WEEKLY CHART

- LONG TERM TRENDLINE BREAKOUT DONE ✔️

- INVERSE H&S BREAKOUT DONE ✔️

JOCIL 167.4 ❤️

ZOOOMING 🚀🚀

BDL:

INDIA IS WORKING ON INTEGRATING THE RVV-BD LONG-RANGE AIR-TO-AIR MISSILE WITH ITS SU-30 MKI FLEET, POTENTIALLY GIVING THE IAF A MAJOR BOOST IN BEYOND-VISUAL-RANGE AIR COMBAT CAPABILITY.

SMS pharma:

our special note on their new capabilities will be out!

SAMMIR D. DATTANI, SANATHAN TEXTILES

Doubled Capacity Of Technical Textiles To 18,000 mtpa

Technical Textiles Revenue To Double To Around ₹300 Cr Annually

Technical Textiles Space Will Be Margin Accretive

Reiterate Rev Target Of ₹5,700-5,800 Cr, & EBITDA Target Of 530-550 Cr In FY27

Will Achieve 80% Capacity Utilisation In Punjab Facility

Expect EBITDA Of Around ₹800-900 Cr By FY28

Maruti Suzuki Announces Price Hike Up to Rs. 20,000 from Sep 2026 | MCap 3,99,291.27 Cr

- Price increase on selected models by up to Rs. 20,000
- Effective from September 2026
- Driven by sustained increase in input costs
- Adverse cost environment with elevated inflationary burdens
- Company mitigates cost impact through cost reduction measures
- Constrained to pass on a portion of increased costs

GODREJ CONSUMER : TARGETING DOUBLE-DIGIT GROWTH 📈

• Targets double-digit volume & profit growth, with revenue growth expected in the high teens

• Speedboats seen as future high-growth categories; company expects 20–30%+ growth

• Core categories have remained flattish for some time

• New strategy aims to bring an “And Culture”, scaling core business from flattish growth to mid-single-digit growth

• Muuchstac integration successful over the last 8–9 months

• Launching G-Lab to accelerate product launches to consumers through the D2C channel

• Company looking to change its operating rhythm for faster execution

• Plans to double R&D capabilities; scale-up expected over 1–1.5 years at a cost of ~₹200 Cr annually

• Evaluating India-focused M&A targets; no immediate acquisition closure expected

• Digital marketing team size to increase 10x over the next 12–15 months

Morepen Labs has successfully
completed the 1st phase of its manufacturing capacity expansion program ahead of the
previously indicated timeline.

~Under this 1st phase, the Company’s installed reactor capacity for API and CDMO has increased from 535 KL to 614 KL.

~This capacity enhancement strengthens the Company’s manufacturing readiness for the ongoing scale-up of commercial CDMO supplies, while also supporting its existing API business and future customer programs